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Abstract
Telomeres protect the chromosome ends and consist of guanine-rich repeats coated by specialized proteins. Critically short
telomeres are associated with disease, aging and cancer. Defects in telomere replication can lead to telomere loss, which
can be prevented by telomerase-mediated telomere elongation or activities of the Werner syndrome helicase/exonuclease
protein (WRN). Both telomerase and WRN attenuate cytotoxicity induced by the environmental carcinogen hexavalent
chromium (Cr(VI)), which promotes replication stress and DNA polymerase arrest. However, it is not known whether Cr(VI)-
induced replication stress impacts telomere integrity. Here we report that Cr(VI) exposure of human fibroblasts induced
telomeric damage as indicated by phosphorylated H2AX (cH2AX) at telomeric foci. The induced cH2AX foci occurred in S-
phase cells, which is indicative of replication fork stalling or collapse. Telomere fluorescence in situ hybridization (FISH) of
metaphase chromosomes revealed that Cr(VI) exposure induced an increase in telomere loss and sister chromatid fusions
that were rescued by telomerase activity. Human cells depleted for WRN protein exhibited a delayed reduction in telomeric
and non-telomeric damage, indicated by cH2AX foci, during recovery from Cr(VI) exposure, consistent with WRN roles in
repairing damaged replication forks. Telomere FISH of chromosome spreads revealed that WRN protects against Cr(VI)-
induced telomere loss and downstream chromosome fusions, but does not prevent chromosome fusions that retain
telomere sequence at the fusion point. Our studies indicate that environmentally induced replication stress leads to
telomere loss and aberrations that are suppressed by telomerase-mediated telomere elongation or WRN functions in
replication fork restoration.
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Introduction
Telomeres are highly specialized chromatin structures consist-
ing of tandem repeats of the TTAGGG sequence bound and
regulated by telomeric proteins (shelterin) and a plethora of
accessory factors. Located at the ends of linear chromosomes,
telomeres prevent the DNA damage response (DDR) and repair
machineries from recognizing and processing the ends as double-
strand breaks (DSBs) [1]. Extensive loss of telomeric DNA and
proteins induce telomere dysfunction and activation of numerous
DDR proteins at the telomeres including phosphorylated histone
H2AX (cH2AX), resulting in telomere dysfunction-induced foci
(TIFs) [2,3]. Telomere dysfunction causes chromosomal instabil-
ity, growth arrest (senescence) or cell death [1]. Telomerase is a
ribonucleotide enzyme that lengthens eroded telomeres to
maintain cellular proliferative capacity and genome integrity [4].
However, most human somatic cells lack sufficient telomerase
activity to prevent telomere shortening that occurs with every
replicative cycle [5]. Defects in telomere length homeostasis and
telomerase activity are associated with numerous human diseases
including progeroid syndromes, cancer, bone marrow failure, and
pulmonary fibrosis [6].
Accumulating evidence indicates that replication fork stalling or
collapse at telomeric ends can lead to telomere loss or aberrations.
Telomeric instability associated with defects in telomere replica-
tion are induced by polymerase inhibitors and agents that stabilize
DNA G-quadruplexes or by depletion of shelterin TRF2 or POT1
proteins [7,8,9]. Loss of the WRN helicase/exonuclease results in
Werner syndrome (WS), which is characterized by features of
premature aging and cancer predisposition [10]. Cellular data
support roles for WRN in the processing of stalled replication
forks, and the recovery from replication stress [11,12,13]. The
premature senescence, genomic instability and stochastic telomere
loss phenotypes of WS cells can be rescued by expressing either
WRN protein or telomerase [14]. These data indicate that
telomerase can compensate for WRN roles at telomeric ends.
WRN has been implicated in telomere replication. WRN localizes
to telomeres in S-phase telomerase deficient cells and interacts
with shelterin proteins TRF2 and POT1 [14,15,16]. WRN
defective cells exhibit increased telomere loss particularly on sister
chromatids replicated from the G-rich telomere strand [14]. These
studies indicate that shelterin proteins together with telomerase or
accessory proteins, such as WRN, are required to prevent telomere
abnormalities resulting from endogenous obstacles to telomeric
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replication. However, their importance in protection against
telomere loss due to exogenous or environmental effectors of
replication stress is not known.
The environmental metal hexavalent chromium (Cr(VI)) is an
important source of DNA replication stress. The inhalation of
Cr(VI) particles is strongly linked to respiratory cancers in the
occupational setting [17], and short telomeres are associated with
increased risk for lung cancer [18]. The expression of telomerase
in human fibroblasts significantly reduces Cr(VI)-induced cellular
toxicity and genomic instability, however, Cr(VI) exposure does
not significantly alter mean telomere lengths [19,20]. Whether
Cr(VI) impacts the integrity of individual telomeres, or induces
telomeric abnormalities is unknown. Cr(VI) reduces to Cr(III) in
cells which reacts with DNA and produces a broad array of lesions
[21]. Guanine runs are hotspots for Cr(VI) mediated base
substitutions and deletions, Cr-DNA adducts and further oxida-
tion of 8-oxo-guanine [22,23]. Importantly, Cr(VI) treatment of
DNA templates in vitro induces DNA polymerase arrest with the
most potent arresting lesions at G runs [24,25]. Consistent with
this, Cr(VI) exposure induces replicative stress indicated by S-
phase arrest and S-phase dependent DSBs [24,26,27] which likely
result from replication fork collisions with blocking lesions. Defects
in DNA repair proteins that maintain replication fork stability,
including WRN, lead to Cr(VI) hypersensitivity [11,12,28,29,30].
These findings indicate that telomeric repeats may be particularly
vulnerable to Cr(VI) induced lesions that stall replication. The
consequence of environmentally induced replication stress on
telomere integrity is largely under-investigated.
In this study we examined whether Cr(VI)- induced replication
stress impacts telomere integrity at the molecular and chromo-
somal level. We further tested the hypothesis that WRN and
telomerase protect against Cr(VI)-induced cytotoxicity and
genomic instability, partly by preventing Cr(VI)-induced telomere
defects. We found that Cr(VI) exposure in human cells induces
telomeric damage as indicated by telomere dysfunction induced
foci (TIFs), and telomeric abnormalities associated with defects in
telomere replication including telomere loss on chromatids. The
latter was attenuated by telomerase expression, and exacerbated
by WRN depletion. Thus, we provide novel evidence that
environmentally induced replicative stress can impact telomere
integrity, and offer a mechanistic explanation for the increased
sensitivity of WRN and telomerase deficient cells.
Results
Telomerase protects against Cr(VI)-induced cytotoxicity
and telomere instability
Previous studies showed that exposure to Cr(VI) significantly
reduced survival of TERT- BJ cells compared to the TERT+ BJ cells
[19,20]. While Cr(VI) exposure did not alter mean telomere lengths
in either cell line [19], the impact on telomere integrity was not
examined. We predicted that telomerase may protect against Cr(VI)
toxicity and genomic instability by preventing induced telomeric
defects and dysfunction. First we confirmed the protective effect of
telomerase against Cr(VI) toxicity by testing cell survival and
replicative capacity of exposed cells [11]. After 48 h Cr(VI) exposure
cellular sensitivity was not affected by telomerase status (Figure 1A),
suggesting no significant difference in survival immediately following
Cr(VI) exposure. However, TERT- cells demonstrated hypersensi-
tivity at both 0.5 and 1 mM Cr(VI) compared to TERT+ cells
(greater than 25% difference in survival) after 8 days of subculturing
in Cr(VI)-free medium. Our data indicate that TERT- cells
exhibited a significantly reduced capacity to recover and proliferate
after Cr(VI) exposure, compared to TERT+ cells.
To determine whether Cr(VI) exposure can induce telomeric
defects and whether telomerase can protect against such telomere
instability, we examined individual telomeres in TERT- and
TERT+ BJ cells after 0.5 mM Cr(VI) exposure for 48 h, followed
by 10 h recovery. Telomeres on metaphase chromosome spreads
were visualized by telomere fluorescent in situ hybridization (Telo-
FISH) with a PNA probe (Figure 1B) [31]. Telomere defects
manifested as telomere signal free ends (SFEs, lacking detectable
telomere signal at one or more sister chromatids), sister telomere
fusions (STFs), telomere doublets (the presence of more than one
telomere signal at a chromatid end), and telomere-containing
chromosome/chromatid fusions (T-CFs). Cr(VI) exposure increased
the incidence of all types of the detectable telomeric defects more
than two fold in TERT- BJ cells (Figure 1C). Importantly, telomerase
expression dramatically reduced the incidence of SFEs by 28-fold
after Cr(VI) exposure (5.6% of chromosomes in TERT- cells
compared to 0.2% of chromosomes in TERT+ cells) (Figure 1C).
Additionally, Cr(VI)-induced SFEs in TERT+ BJ was reduced 3.5-
fold compared to untreated cells (0.7%). This strongly suggests the
SFEs were due to telomere loss or truncation and not chromosome
breaks in the sub-telomeric or genomic regions. While Cr(VI)
induced a near 3-fold increase in SFEs in TERT- cells, compared to
the untreated cells, no such induction occurred in TERT+ cells.
Furthermore, nearly 2-fold reductions in Cr(VI)-induced STFs and
T-CFs were observed in TERT+ cells compared to TERT- cells, but
the induction of telomere doublets was not influenced by telomerase
expression (Figure 1C, Table S1). In agreement with previous
reports [19], we observed that 0.5 mM Cr(VI) induced chromatid
breaks in TERT- cells (3/30 metaphases) (Table S1), but not in
TERT+ cells. In summary we confirmed that telomerase protects
against Cr(VI) cytotoxicity, and observed that telomerase expression
dramatically reduced the incidence of Cr(VI) induced telomere
signal free ends, consistent with protection against telomere loss.
Cr(VI) induces telomere damage associated with cells in
S-phase
Occupational Cr(VI) exposure poses a well established risk for
developing lung cancer [21]. To investigate if Cr(VI) induces
telomere instability in a relevant cell line for Cr(VI) carcinogenesis,
we tested its effects in WI-38 lung fibroblasts. Interestingly, WI-38
cells were more resistant to low-level Cr(VI) exposure than skin BJ
cells (Figures 1A and 2A). However, similar to BJ cells, theWI38 cells
exhibited reduced survival and proliferation after an 8-day recovery
from Cr(VI) exposure (Figure 2B). Based on the increased resistance
of WI38 cells to Cr(VI), we examined their telomere damage with
higher but still occupationally relevant Cr(VI) concentrations.
Telomere dysfunction-induced foci (TIFs) refer to the colocaliza-
tion of DNA damage response factors with telomeres, and are
widely used to investigate factors that induce telomere instability
including compromised shelterin proteins or G4 stabilizing agents
[2,7]. Whether environmental genotoxins can induce TIFs is
unknown. While we adopted the commonly used TIF term [2], in
our studies these foci refer to telomere damage and not necessarily
to un-repairable loss of telomere function. To test for TIF induction,
WI-38 cells were exposed to Cr(VI) for 48 h and then subjected to
IF-FISH to detect cH2AX colocalization with a telomeric peptide
nucleic acid (PNA) probe. Both 2 and 4 mM Cr(VI) induced
significant formation of cH2AX foci (more than 3 fold) and TIFs
(more than 4 fold), and increased the percent of TIF positive cells
(Figure 2C). In contrast, 1 Gy c-irradiation, which induces random
genome-wide DSBs, stimulated cH2AX formation comparable
with 2 mM Cr(VI), but the TIF level was similar to the untreated
group (Figure 2C). Our data indicate that while both c-irradiation
Induced Telomere Instability
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and Cr(VI) exposure induced cH2AX foci, only Cr(VI) induced a
significant increase in DNA damage foci associated with telomeres.
Low levels of Cr(VI) exposure for 6–24 h induces replicative
stress, indicated by cH2AX association with S phase cells
[11,26,32]. Therefore, we predicted that the Cr(VI) induced TIFs
occurred as a result of replicative stress at the telomeres. To test this
we exposed WI38 cells to 4 mM Cr(VI) for 48 h, followed by pulse
labeling with BrdU nucleotide analog, and determined cH2AX
association with S phase cells by dual immunostaining (Figure 2D-
E). BrdU negative cells displayed similar low levels of cH2AX foci
number (peak near 1) in both the untreated and Cr(VI) treated cells.
In contrast, the percent distribution in BrdU positive cells shifted
towards the right, indicating increased cH2AX foci number with a
peak at 9 for the untreated cells and a peak at 15 with a broader
spread toward higher foci number after Cr(VI) treatment. Thus,
Cr(VI) induced cH2AX foci in WI38 cells occurs in S-phase,
consistent with results for other cell lines [11,26]. Furthermore, the
Cr(VI)-induced TIFs occurred in cells with higher numbers of
cH2AX foci as observed in the BrdU positive cells. Of the Cr(VI)
treated cells with .5 cH2AX foci, 93% (50/54) were TIF positive
and 90% (69/77) were BrdU positive, indicating the TIF formation
mechanism is most likely related to replication stress.
Cr(VI) induces telomere defects in lung fibroblasts
To directly evaluate the consequence of Cr(VI)-induced
telomere damage on telomere structure and integrity we stained
individual telomeres on chromosome metaphase spreads using the
Telo-FISH assay (Figure 3A). The total level of telomeric defects
was significantly increased by 6.3 fold after 4 mM Cr(VI) exposure
(Figure 3B). While all four types of telomeric defects, including
SFEs, STFs, T-CFs and doublets were significantly increased
(Figure 3B), the SFEs and STFs occurred at the highest
frequencies. In both the untreated and Cr(VI)-treated group, most
of the SFEs occurred at one chromatid end and the T-CFs were
mainly chromatid fusions (data not shown). Although the levels of
the doublets were lower than SFEs and STFs, the fold induction
was higher (13-fold) compared to that of SFEs (7-fold) and STFs
(7-fold). These data indicate that Cr(VI) exposure at low levels
induces telomere instability in a relevant cell line for inhalation
exposure.
WRN protects against Cr(VI) cytotoxicity and localizes to
telomeres upon Cr(VI) exposure
Biochemical and cellular evidence support WRN roles in
facilitating telomere replication, and in recovery from replication
fork stalling [10,33,34]. Recently, we and others found that WRN
protects against Cr(VI)-induced replicative stress [11,12]. We
reported that WRN depletion by shRNA increased cellular
sensitivity to Cr(VI) by a cell viability assay [11], and confirmed
this result here using the more rigorous clonogenic assay. The
colony numbers from all Cr(VI) concentrations in the WRN
deficient cells were significantly lower than the control cell line
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Figure 1. Telomerase expression attenuates Cr(VI)-induced cytotoxicity and telomere aberrations. (A) Cell viability assay. The cells were
exposed to the indicated Cr(VI) concentrations for 48 h, and subpopulation of Cr(VI)-treated cells were subcultured in Cr(VI)-free medium for 8 days. (B)
Images are representative telomere FISH of partial metaphases from cells exposed to 0 or 0.5 mM Cr(VI) for 48 h and cultured in Cr(VI)-free medium for
10 h. Arrows heads indicate telomeric defects that appeared in each of the focal planes of the Z-stack series (see Materials and Methods), although only
one focal plane is shown. (C) Frequencies of Cr(VI)-induced telomere aberrations. Values in parenthesis indicate the number of abnormal chromosomes/
total chromosomes. Telomere signal free ends, SFEs; sister chromatid telomere fusions, STFs. Insets show examples of two SFEs, followed by two STFs.
doi:10.1371/journal.pone.0011152.g001
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Figure 2. Cr(VI) induces replication-associated TIFs in lung fibroblasts. (A) Cellular toxicity of Cr(VI) upon 48 h exposure followed by no
recovery or an 8-day recovery of a subpopulation of WI-38 cells in Cr(VI)-free medium. The symbol (*) indicates a significant difference from untreated
in the indicated Cr(VI) concentration (p,0.05). (B) Confocal images of WI-38 cells exposed to the indicated Cr(VI) concentrations for 48 h. Cells were
subjected to IF-FISH for analysis of cH2AX (green) and telomere (red) colocalization (yellow). IR: 1 Gy treatment, followed by IF-FISH after 1 h
recovery. Bars, 10 mm. (C) Average cH2AX foci and TIF number per cell and the percent of TIF positive cells (% TIF+ cells). The % TIF + cells represent
the percentage of cells containing at least one TIF foci. The data represent mean 6SE from two independent experiments, based on at least 50
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(Figure 4A). Telomerase can compensate for WRN roles in
protection against telomere loss, replicative senescence and
chromosome aberrations [35]. Similarly, we observed that
ecotopic expression of telomerase dramatically reduced the
sensitivity of WS cells to Cr(VI) toxicity (Figure 4B). This suggests
that telomerase can at least partially compensate for WRN roles in
protection against Cr(VI) toxicity.
Upon Cr(VI) exposure WRN re-localizes from the nucleoli into
nucleoplasmic foci in S-phase cells that co-localized with cH2AX
foci [11]. Next, we investigated whether WRN localizes to
telomeres in response to Cr(VI)-induced DNA damage using a
telomerase negative U2OS cell line that stably expresses an EYFP-
WRN fusion protein [15]. EYFP-WRN responds similarly to
Cr(VI) treatment as endogenous WRN [11]. We evaluated
telomere colocalized WRN foci (TWFs) by two criteria: (1) the
average colocalized foci number per cell and (2) the percent of cells
showing colocalization. Cr(VI) exposure induced a concentration-
dependent increase in both WRN-telomere colocalization criteria
(Figure 4D). At 4 mM Cr(VI) the colocalization induction was
significantly higher at 48 h exposure (15-fold) compared to 24 h
exposure (5-fold), indicating that WRN response to Cr(VI)-
induced damage at telomeres is both concentration and time
dependent.
WRN functions in recovery from Cr(VI)-induced telomere
damage
Next, we asked whether the pattern of WRN foci localization is
associated with Cr(VI)-induced telomere damage, as indicated by
TIFs. The Cr(VI) cellular exposure experiment in Figure 4 also
induced a concentration-dependent increase in cH2AX foci and
TIF formation (Figure 5B), as observed for WI38 cells. In addition,
a significant difference was observed between 24 and 48 h at 4 mM
Cr(VI) with regard to TIF formation, but not cH2AX formation,
suggesting increased telomere specific damage upon Cr(VI)
randomly chosen cells for each Cr(VI) treatment. Bars with a different number of symbols are significantly different from each other (p,0.05). (D)
Confocal images of cH2AX (red) association with S-phase cells, indicated with BrdU incorporation (green). Cells were exposed to 4 mM Cr(VI) for 48 h
and then subjected to BrdU pulse labeling, followed by double immunostaining. (E) The frequency distribution of BrdU-negative and -positive cells is
plotted against the number of cH2AX foci in the cells, based on a minimum of 120 randomly chosen cells from each Cr(VI) treatment.
doi:10.1371/journal.pone.0011152.g002
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Figure 3. Cr(VI) induces telomere instability in lung fibroblasts. (A) Representative telomere FISH of full metaphases from cells exposed to
the indicated Cr(VI) concentrations for 48 h and cultured in Cr(VI)-free medium for 10 h. (B) Cr(VI)-induced telomere instability. Approximately 60
metaphases from two independent experiments were analyzed to quantitate Cr(VI)-induced telomere defects. Bars with a symbol are significantly
different from the untreated (p,0.05). The data represent mean 6SE from two independent experiments. Telomere signal free ends, SFEs; sister
chromatid telomere fusions, STFs; chromosome/chromatid fusions with telomere signal at the fusion, T-CF.
doi:10.1371/journal.pone.0011152.g003
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treatment for a longer time. A time dependent increase was also
observed for WRN co-localization to telomeres after 4 mM Cr(VI)
exposure (Figure 4C), indicating the pattern of Cr(VI) induced TIF
formation and WRN localization is similar (Figures 4C and 5B).
To test whether WRN functions in repair of Cr(VI)-induced
telomere damage, we employed U2OS cell lines that stably express
either a short hairpin (sh) RNA targeting WRN mRNA or a
control shRNA [11]. These two cell lines exhibited similar levels of
cH2AX and TIFs immediately after Cr(VI) exposure (Figure S1).
However, we previously observed that WRN deficiency results in
slower reduction of cH2AX foci during recovery from Cr(VI) [11].
We asked whether this occurred with respect to Cr(VI)-induced
TIFs. Cells were exposed to 4 mM Cr(VI) for 48 h, then cultured
in Cr(VI)-free medium for 12 h, and then assayed for the average
cH2AX foci, TIFs, and non-telomeric cH2AX foci per cell, as well
as the percent TIF positive cells, compared to 0 h recovery.
Following the recovery in Cr(VI)-free medium, all parameters
showed a significant reduction in the shCtrl cells (Figure 5C).
Interestingly, the reduction in telomeric cH2AX and non-
telomeric cH2AX was similar, indicating no particular bias for
repair of telomeric vs. non-telomerc damage. In sharp contrast,
the WRN depleted cells did not exhibit a significant reduction in
Cr(VI) induced telomeric or non-telomeric damage after recovery.
These data strongly suggest that WRN does not prevent Cr(VI)-
induced stalled replication forks or DSBs at telomeric or non-
telomeric sites, but acts to repair Cr(VI)-induced damage, most
likely damaged replication forks, during recovery.
WRN protects against Cr(VI) induced telomeric defects
Based on the evidence that WRN depleted cells exhibit reduced
recovery from telomere damage (Figures 4-5), we asked if WRN
prevents Cr(VI) induced telomeric defects. For this purpose,
telomeres were stained on chromosome metaphase spreads to
visualize telomeric defects in WRN deficient cells compared to
controls. We first attempted to knock down WRN expression in
WI38 lung cells, however, using two strategies for shWRN
expression via retrovirus or lentivirus [36,37] we were unable to
recover viable cells. Furthermore, attempts to recover metaphase
spreads after Cr(VI) exposure of WS cells was unsuccessful,
although untreated WS cells did yield metaphase spreads. This is
likely due to WRN roles in recovery from Cr(VI)-induced
replicative stress. As an alternative strategy, we used the shCtrl
and shWRN U2OS cell lines in this experiment. U2OS cells are
telomerase negative and use the alternative lengthening telomere
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(ALT) pathway to maintain telomere status [38]. Importantly,
WRN depletion in U2OS cells does not impair proliferation [37],
but does increase sensitivity to Cr(VI) toxicity (Figure 4).
To directly test Cr(VI)-induced telomeric defects in WRN
depleted cells, compared to WRN proficient cells, the shWRN and
shCtrl U2OS cell lines were exposed to 3 mM Cr(VI) for 48 h and
recovered in Cr(VI)-free media with colcemid for 10 h. We
observed several types of telomeric defects [39] (Figure 6A, Figure
S2), and compared exposed to unexposed cells (* = significant
difference) within the same cell line, as well as exposed shWRN to
exposed shCtrl cells (# = significant difference). After Cr(VI)
exposure the incidence of telomere loss (signal-free ends, SFEs)
increased in both shCtrl and shWRN cells, compared to untreated
cells, but the levels of SFEs was significantly higher in shWRN cells
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Average cH2AX foci and TIF number per cell and the percent of TIF positive cells. Bars with a different number of symbols are significantly different from
each other within each treatment time point (p,0.05). (C) Recovery kinetics of DNA damage and TIFs following Cr(VI) treatment. Cells were exposed to
4 mM Cr(VI) for 48 h and then cultured in Cr(VI)-free medium for 12 h. The values at 12 h recovery were expressed as percent of the values at 0 hr
recovery (immediately after the 48 h Cr(VI) treatment). The average number of cH2AX foci, TIFs and non-telomeric cH2AX foci per cell was calculated
along with the percent of TIF positive cells. The data represent mean 6SE from two independent experiments, based on at least 50 randomly chosen
cells for each Cr(VI) treatment. Symbol(s) above a bar indicates significantly different from the values at 4 mM Cr(VI) treatment for 48 h (p,0.05).
doi:10.1371/journal.pone.0011152.g005
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compared to exposed shCtrl cells (#) (Figure 6B). In contrast, this
pattern was reversed with respect to sister telomere fusions (STF),
since Cr(VI)-induced STFs was significant in shCtrl cells compared
with a slight but non-significant induction in shWRN cells
(Figure 6B). Consistent with the significant increase in telomere
loss (SFEs) in exposed shWRN cells, chromosome/chromatid
fusions that lacked telomere signal at the fusion point (SF-CFs)
were also significantly increased in exposed shWRN cells
compared to untreated shWRN cells (*) and exposed shCtrl cells
(#) (Figure 6B). However, while Cr(VI) exposure induced a
significant increase in chromosome/chromatid fusions that retain
telomere sequence at the fusion point (T-CF) in both cells lines, the
T-CF levels in exposed shCtrl cells were significantly higher than
in exposed shWRN cells (#) (Figure 6B). Together these data
support a role for WRN in preventing Cr(VI) induced telomere
loss on sister chromatids that can lead to chromosome or
chromatid end fusions that lack a telomere signal. However,
WRN was not effective in preventing Cr(VI) induction of
chromatid and chromosome fusions that retained telomere
staining at the point of fusion.
Recent reports indicate that WRN prevents the induction of
chromatid breaks at fragile sites due to replication fork stalling
[40], and Cr(VI) exposure is known to induce chromatid breaks
[21]. An average of 0.28 spontaneous chromatid breaks per
metaphase was observed in shWRN cells, but not in control cells
(Figure 6B). Cr(VI) exposure induced a significant increase in
Figure 6. WRN protects against Cr(VI) induced telomere loss. (A) Representative telomere FISH of partial metaphases and telomere defects
from shCtrl and shWRN cells exposed to 0 and 3 mM Cr(VI) for 48 h and cultured in Cr(VI)-free medium for 10 h. (B) Cr(VI)-induced telomere instability.
Approximately 40 metaphases from two independent experiments were analyzed to quantitate Cr(VI)-induced telomere defects. Bars with a symbol
of * indicates a significant difference between 0 and 3 mM in the same cell line and bars with a symbol of # indicates significant difference between
exposed shCtrl and shWRN cells (p,0.05). Telomere signal free ends, SFE; telomere sister chromatid fusions, SFT; chromosome/chromatid fusions
lacking a telomere signal, SF-CF; chromosome/chromatid fusion with telomere signal at the fusion, T-CF; break indicates chromatid break. (C) Model
for roles of WRN and telomerase in protection against Cr(VI)-induced telomere damage.
doi:10.1371/journal.pone.0011152.g006
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chromatid breaks in both cell lines, however, the break incidence
in exposed shWRN cells was significantly higher than in exposed
shCtrl cells (3.4-fold) (Figure 6B). In summary, our these data
support a role for WRN in the protection against Cr(VI) induced
telomere loss and chromatid breaks.
Discussion
Telomere instability is linked to human diseases and cancer
development, and several reports indicate that telomeres are
vulnerable to oxidative and replication stress. Cr(VI) is an
environmental lung carcinogen that induces lesions that interfere
with DNA replication. In this study, we show that Cr(VI) exposure
leads to telomere damage and chromosomal telomere loss and
aberrations associated with Cr(VI)-induced replication stress.
Telomerase expression alleviates Cr(VI)-induced telomere insta-
bility, and may explain the hypersensitive phenotype of telomerase
negative cells to Cr(VI) toxicity. WRN protein promotes
replication fork recovery and telomere replication [37], and we
found that WRN depletion leads to Cr(VI) hypersensitivity that
can be rescued by telomerase. Furthermore, WRN localizes to
Cr(VI) induced damaged telomere foci where it promotes their
reduction and repair during recovery in Cr(VI)-free media. WRN
depletion increased the incidence of chromosomal telomere loss
and chromatid breaks induced by Cr(VI) exposure, consistent with
roles for WRN in promoting telomere preservation after
replication stress. Collectively, our data suggest that environmen-
tally induced replication stress by DNA damaging agents that
target G runs can promote telomere instability and aberrations.
Telomerase confers cellular resistance to genotoxins with
different modes of action [41]. Similar to previous reports, we
found that telomerase expression decreased sensitivity to Cr(VI)-
induced toxicity in BJ foreskin fibroblasts [19,20] (Figure 1). The
protective effect of telomerase was associated with significantly
lowered apoptosis, senescence, and genomic instability [19].
Surprisingly, the mean telomere lengths were not significantly
altered [19], which suggested that telomerase may confer resistance
by inhibiting apoptosis or a bystander effect that induces DNA
damage in neighboring cells [42]. However, these studies used
STELA to measure the distribution of individual telomere lengths
which relies on an intact telomeric 39 tail [19,43]. WS cells also did
not exhibit differences in telomere length by STELA [44], but
showed an increase in telomere loss on sister chromatids by telo-
FISH that was rescued by telomerase [14,35]. Similarly, we
observed that Cr(VI) significantly increased chromosomal telomere
loss, indicated by telomere signal free ends, and sister telomere
fusions that were rescued by telomerase (Figure 1B and C). These
telomere chromosomal aberrations compromise the telomere 39tail
and thus, cannot be detected by STELA. However, the same study
that examined telomere length by STELA also found that Cr(VI)
induced dicentric chromosomes and nucleoplasmic bridges in the
hTERT- BJ cells [19], which can result from the fusion of
dysfunctional telomeres [35]. Therefore, our findings that Cr(VI)
exposure induces telomere loss and telomere fusions in both skin
and lung telomerase negative cell lines (Figures 1 and 3) are
consistent with their results. It is worth noting that a previous study
found telomerase did not alter the sensitivity of bronchial fibroblasts
to particulate Cr(VI) [45], which may be due to differences in
particulate versus soluble chromium and cell lines. Never-the-less,
our data provide novel evidence that Cr(VI) exposure induces
telomere aberrations than can be rescued by telomerase.
Together with previous work our findings support a role for
Cr(VI)-induced replication stress in generating telomeric defects,
rather than oxidative stress which can be induced by genotoxic
metals and can target telomeres for damage. Guanine is particularly
susceptible to oxidative damage and chronic oxidative stress
accelerates telomere attrition [46]. Environmental metals can
induce reactive oxygen species (ROS), and oxidative stress
contributes to arsenic induced apoptosis, accelerated telomere
shortening and chromosome aberrations, which are attenuated by
telomerase activity [47,48]. However, Cr(VI) exerts its genotoxic
effects through different mechanisms. Although Cr(VI) at higher
concentrations can induce ROS, the mutagenic and genotoxic
effects at occupationally relevant levels are ascribed to various Cr-
DNA and Cr-protein-DNA adducts that impede replication fork
progression particularly at G-runs as in telomere repeats
[11,24,25,28]. Together with these reports, our results strongly
support roles for replicative stress in Cr(VI) induced telomere
instability, rather than oxidative stress. First, Cr(VI) exposure results
in the accumulation of cells in S-phase [11,24,49], and cH2AX foci
formation in S-phase cells (Figure 2E). These results indicate that
the Cr(VI) induced cH2AX foci at telomeres (TIFs) we observed
primarily occurred in S-phase cells (Figure 2C), consistent with
replication fork stalling at telomeres. Second, WRN protein
localizes to telomeres upon Cr(VI) exposure associated with
telomere damage (Figures 4C and 5). Similarly, WRN is recruited
to telomeres in S-phase in response to a G-quadruplex stabilizing
agent that interferes with telomere replication [7]. Third, Cr(VI)
exposure leads to various types of chromosomal telomeric defects in
both skin and lung primary fibroblasts (Figures 1 and 3), that were
also induced with the G-quadruplex stabilizing agents [7,50].
Finally, our experiments were conducted at 5% O2 to mimic
physiological conditions and minimize oxidative stress induced by
culture conditions, and while oxidative stress causes accelerated
shortening of mean telomere lengths [47], Cr(VI) exposure does not
[19]. These results indicate that environmentally induced DNA
replicative stress can induce telomeric aberrations.
WRN is implicated in telomere preservation by resolving
alternate structures at telomeres during replication, and by
restoring stalled or broken replication forks [10,33]. Our data
indicate that WRN responds to Cr(VI) induced telomere damage.
The hypersensitivity of WRN deficient cells to Cr(VI) toxicity is
greatly reduced by telomerase expression (Figure 4), and Cr(VI)
induced WRN localization to telomeres correlates well with
telomere damage foci (Figure 4B). However, we found WRN does
not prevent telomere damage or stalled forks indicated by cH2AX
foci or TIF formation upon Cr(VI) exposure (Figure S1). This is
consistent with reports that WRN does not stabilize the disrupted
replication forks upon replication stress, but rather facilitates
recovery of the replication forks [11,51,52]. WRN depletion
delayed significantly the reduction in telomeric and non-telomeric
cH2AX foci during recovery in Cr(VI) free media (Figure 5C),
indicating that WRN likely functions in the repair of stalled or
broken replication forks at genomic and telomeric loci.
WRN prevents stochastic telomere loss presumably by facilitat-
ing telomere replication and resolving alternate structures [14].
We now report that WRN is also important for preventing
telomere loss induced by environmental sources of replication
stress. Cr(VI) exposure led to a significant increase in chromo-
somal ends and fusions that lack telomere signals in WRN
deficient U2OS cells, compared to WRN proficient cells (Figure 6).
Telomere dysfunction leads to repair by non-homologous end
joining or homologous recombination that can induce chromo-
some or chromatid fusions [8,53]. When chromosome fusions are
caused by telomere deprotection, such as loss of shelterin proteins,
the TTAGGG repeats are maintained and appear at the fusion
sites [8,54]. However, the increased Cr(VI) induced fusions in
WRN depleted cells lacked detectable TTAGGG repeats at the
Induced Telomere Instability
PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e11152
fusion sites, suggesting the fusions resulted from telomere loss.
Consistent with this, WS fibroblasts in which p53 and Rb were
inhibited exhibit spontaneous chromosome fusions and anaphase
bridges that lack telomere repeats at the fusion points, and that are
prevented by telomerase [35]. Telomerase-mediated elongation of
critically short or missing telomere ends may compensate for
WRN, and rescue the hypersensitivity of WS cells to Cr(VI). In
contrast, WRN depletion in U2OS cells led to a reduction in
Cr(VI) induced chromosome and chromatid fusions that retain
detectable telomere sequence at the fusion site (Figure 6), and
presumably resulted from telomere deprotection due to shelterin
protein dysfunction rather than telomere loss. Previous reports
indicate that in the absence of proper regulation by shelterin
proteins, the WRN homolog in yeast can promote aberrant
processing, chromosome fusion and telomere loss [55,56]. For
example, telomeric POT1 inhibits WRN exonuclease digestion of
telomeric 39overhangs [57,58]. Inappropriate processing by WRN
can be detrimental since a recent report found WRN induces slow
growth of top3 mutant yeast strains [59]. Our study provides the
first molecular evidence that WRN protects against environmen-
tally induced telomere loss and downstream chromosome/
chromatid fusions associated with replication stress.
In summary, our data show that environmentally induced
replication stress can lead to telomeric aberrations and instability
that are attenuated by telomerase expression or WRN protein
activity. Furthermore, our data suggest that telomeric aberrations
contribute to Cr(VI) induced cytotoxcitiy and genotoxicity, and
may contribute to respiratory cancers resulting from Cr(VI)
exposure. Thus, we provide novel evidence that an environmental
pollutant can induce telomere instability, which may contribute to
environmentally relevant diseases including cancer.
Materials and Methods
Cell lines and culture conditions
Werner syndrome (WS) skin fibroblasts (AG03141) and WI-38
lung fibroblasts were from the Coriell Institute (Camden, NJ). The
telomerase-immortalized WS cell line (AG03141) was a gift from
Dr. Junko Oshima (University of Washington). BJ and telomerase-
immortalized BJ (hTERT BJ) skin fibroblasts were kindly provided
by Dr. Peter Lansdorp (University of British Columbia). Cells were
cultured in Dulbecco’s Modified Eagle Media (Invitrogen, Carls-
bad, CA) supplemented with 15% fetal bovine serum, penicillin
(50 units/ml), and streptomycin (50 mg/ml) in humidified chambers
with 5% CO2 and 5% O2 at 37uC. Human U2OS osteosarcoma
cell line (ATCC) was cultured similarly except with 10% FBS
[11,15]. U2OS cell lines stably expressing a short hairpin RNA
against WRN (shWRN) or a scrambled control (shCtrl), or stably
expressing WRN with an EYFP fluorescent tag (EYFP-WRN
U2OS) were cultured as described previously [11,15].
Cellular Cr(VI) exposures
Cells were exposed to potassium dichromate (K2Cr2O7; Cr(VI)
(Sigma-Aldrich, St. Louis, MO) as described previously [11], for
either 24 or 48 hr at various concentrations as indicated in the
figure legends. Some experiments included recovery in Cr (VI)-
free media as described in the figure legends. WI-38 cells were
irradiated with 1 Gy of c-irradiation using a Shepherd model 143-
45A irradiator (J. L. Shepherd & Associates, CA) followed by 1 h
recovery as a negative control for DSB formation [60].
Cell survival assays
The cell viability assay (CVA) was conducted as previously
described with slight modification [11]. Following Cr(VI) exposure
46104 cells were subcultured in 10-cm culture dish for 7 days. In
the clonogenic assay, different cell numbers (800–35,000)
depending on Cr(VI) concentrations, were seeded in 6-cm culture
dishes and incubated overnight. After Cr(VI) exposure, the cells
were cultured in Cr(VI)-free medium for 7 days. Then cells were
stained (50% methanol, 7% acetic acid, 0.1% Comassie brilliant
blue) for 15 min, and colonies composed of 25 or more cells were
counted. The survival fraction at each Cr(VI) concentration was
determined by dividing the average number of colonies on treated
plates by the average number of colonies on untreated plates after
adjusting for the initial seeding cell number (plating factor). Each
Cr(VI) concentration exposure was performed in triplicate for
each of four independent experiments.
Immunofluorescence
The association of cH2AX with S-phase cells was detected by
double immunostaining with antibodies against cH2AX and
incorporated BrdU as previously described with slight modifica-
tion [11]. WI-38 cells were exposed to various concentrations of
Cr(VI) then subjected to 10 mM BrdU pulse-label for 30 min [40],
followed by double immunostaining.
Immunofluorescene-Fluoresence In Situ Hybridization
(IF-FISH)
The IF-FISH assay was performed as described previously with
modification [2]. Immediately following Cr(VI) exposures or after
a 12 h recovery period in Cr(VI)-free media as described in the
figure legends, the cells were fixed with 2% paraformaldehyde for
15 min followed by permeabilization and blocking (1 mg/ml BSA,
3% FBS serum, 0.1% Triton X-100, 1 mM EDTA [pH 8.0] in
PBS) for 1 h. Then cells were immuno-stained with mouse anti-
cH2AX monoclonal antibody (1:500; Upstate, Billerica, MA) or
rabbit anti-GFP polyclonal antibody (1:400; GeneTex, Irvine, CA)
[37]. Next, cells were incubated with either Cy5-conjugated goat
anti-mouse (JIR laboratories, Inc., 1:400) or anti-rabbit (JIR
laboratories, Inc., 1:400) or Alexa 488-conjugated (Invitrogen,
1:1000) goat anti-mouse secondary antibody, followed by fixation
in 2% paraformaldehyde for 5 min. Samples were dehydrated in
70%, 95%, 100% ethanol (5 min each) and then denatured for
10 min at 80uC in hybridization solution (70% deionized
formamide, 10% NEN blocking reagent [Roche], 0.1 M Tris-
HCl [pH 7.4], MgCl2 buffer [82 mM NaH2PO4, 9 mM citric
acid, 20 mM MgCl2], and 0.5 mg/ml Cy3-OO-(CCCTAA)3 PNA
probe (Panagene, South Korea)). After 2 h hybridization at room
temperature, the samples were washed twice with wash solution
(70% deionized formamide and 10 mM Tris-HCl [pH 7.4]).
Samples were counterstained with DAPI, mounted onto slides and
images were acquired with an Olympus FluoView 1000 confocal
microscope (Olympus America, Inc., NY) as described previously
[11].
Chromsomal Telomere Fluorescent In Situ Hybridization
(Telo-FISH)
WI-38 (1.06105), BJ (2.06105), hTERT BJ (6.06104), shWRN
U2OS (1.06105) or shCtrl U2OS (1.06105) cells were seeded in
10-cm culture dishes and incubated for 2 days. After Cr(VI)
exposures, the cells were treated with 0.05 mg/ml colcemid
(Invitrogen) for 10 h. Telomere FISH on metaphase chromosomes
was performed as described previously with some modification
[31]. Cells were harvested and treated with 75 mMKCl hypotonic
buffer for 12 min at 37uC and then fixed and stored in methanol/
acetic acid fixative (3:1). Cells were dropped onto slides and aged
overnight. Next, cells were fixed in 4% formaldehyde in PBS for
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2 min, washed with PBS and treated with 0.1% pepsin in 0.01 N
HCl for 10 min at 37uC. Fixation and washing were repeated.
Subsequently, slides were dehydrated in an ethanol series of 70, 90
and 100% for 5 min and air-dried. Then samples were denatured
for 3 min at 80uC in the same hybridization solution as in the IF-
FISH. After 2 h hybridization at room temperature, the slides
were washed twice for 20 min each with wash solution I (70%
deionized formamide, 10 mM Tris-HCl [pH 7.4], and 0.01%
BSA) and three times 15 min each with wash solution II (100 mM
Tris-HCl [pH 7.4], 66.7 mM NaCl, and 0.1% Tween 20). The
samples were counterstained with DAPI and mounted with
coverslips.
The images of metaphases were obtained with Nikon Ti90 epi-
fluorescence microscope (Nikon Inc., NY) equipped with PlanApo
606/1.40 oil immersion objective. The NIS element advanced
software was used to acquire and analyze the images with the same
settings for paired cell lines in each experiment. In order to
rigorously identify and qualify telomere staining and telomere
signal free chromosome ends, fusions and aberrations, a series of z-
stacked images (0.15 mm steps) were acquired for each metaphase
and analyzed. This technique allowed for rigorous distinction of a
telomere signal that was lost from a telomere signal that was out of
focus.
Statistical methods
All statistical analyses were conducted with SAS software (SAS,
Version 9.2, NC). Student t-test was used to determine the
significance of differences between two treatments or time points.
To determine the significance of differences among more than two
treatments or time points, one-way ANOVA followed by Duncan’s
multiple comparison test was employed. The statistically signifi-
cant level was set at p,0.05.
Supporting Information
Table S1 Percent telomere defects (number of defects/number
of chromosomes). The cells were exposed to the indicated Cr(VI)
doses for 48 h and cultured in Cr(VI)-free medium for 10 h.
Found at: doi:10.1371/journal.pone.0011152.s001 (0.70 MB EPS)
Figure S1 WRN does not prevent TIF formation. Confocal
images of shCtrl and shWRN U2OS cells exposed to 4 mM Cr(VI)
for 48 h (A) and then cultured in Cr(VI)-free medium for 12 h (B).
(C) Average cH2AX foci and TIF number per cell and the percent
of TIF positive cells from (A). The data represent mean 6SE from
two independent experiments, based on at least 50 randomly
chosen cells for each Cr(VI) treatment.
Found at: doi:10.1371/journal.pone.0011152.s002 (1.96 MB EPS)
Figure S2 WRN deficiency does not affect Cr(VI)-induced
doublets and telomeric DNA-containing double minute chromo-
somes (TDMs). shCtrl and shWRN cells were exposed to 0 and
3 mM Cr(VI) for 48 h and cultured in Cr(VI)-free medium for
10 h. (A) Average doublets per chromosome. (B) Average TDMs
per chromosome. Around 40 metaphases from two independent
experiments were analyzed to quantitate Cr(VI)-induced telomere
instability.
Found at: doi:10.1371/journal.pone.0011152.s003 (0.70 MB EPS)
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